Literature DB >> 27923833

An Essential Role of Maspin in Embryogenesis and Tumor Suppression.

Sijana H Dzinic1,2, M Margarida Bernardo1,2, Xiaohua Li1,2, Rodrigo Fernandez-Valdivia1,2, Ye-Shih Ho3, Qing-Sheng Mi2,4,5, Sudeshna Bandyopadhyay1,2, Fulvio Lonardo1,2, Semir Vranic6, Daniel S M Oliveira1,2,7, R Daniel Bonfil1,2,7,8, Gregory Dyson2,8, Kang Chen2,4,7,8,9,10, Almasa Omerovic1,2, Xiujie Sheng11, Xiang Han12, Dinghong Wu4,5, Xinling Bi4,5, Dzenana Cabaravdic1,2, Una Jakupovic1,2, Marian Wahba13, Aaron Pang1,2, Deanna Harajli1,2, Wael A Sakr1,2, Shijie Sheng14,2,8.   

Abstract

Maspin (SerpinB5) is an epithelial-specific tumor suppressor gene product that displays context-dependent cellular functions. Maspin-deficient mouse models created to date have not definitively established maspin functions critical for cancer suppression. In this study, we generated a mouse strain in which exon 4 of the Maspin gene was deleted, confirming its essential role in development but also enabling a breeding scheme to bypass embryonic lethality. Phenotypic characterization of this viable strain established that maspin deficiency was associated with a reduction in maximum body weight and a variety of context-dependent epithelial abnormalities. Specifically, maspin-deficient mice exhibited pulmonary adenocarcinoma, myoepithelial hyperplasia of the mammary gland, hyperplasia of luminal cells of dorsolateral and anterior prostate, and atrophy of luminal cells of ventral prostate and stratum spinosum of epidermis. These cancer phenotypes were accompanied by increased inflammatory stroma. These mice also displayed the autoimmune disorder alopecia aerate. Overall, our findings defined context-specific tumor suppressor roles for maspin in a clinically relevant model to study maspin functions in cancer and other pathologies. Cancer Res; 77(4); 886-96. ©2017 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27923833      PMCID: PMC5313336          DOI: 10.1158/0008-5472.CAN-16-2219

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  55 in total

Review 1.  The natural tumor suppressor protein maspin and potential application in non small cell lung cancer.

Authors:  Fulvio Lonardo; Xiaohua Li; Alexander Kaplun; Ayman Soubani; Seema Sethi; Shirish Gadgeel; Shijie Sheng
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

2.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

3.  Ezrin, maspin, peroxiredoxin 2, and heat shock protein 27: potential targets of a streptococcal-induced autoimmune response in psoriasis.

Authors:  Petra Besgen; Paul Trommler; Sigrid Vollmer; Joerg Christoph Prinz
Journal:  J Immunol       Date:  2010-04-02       Impact factor: 5.422

4.  The differential effects of mutant p53 alleles on advanced murine lung cancer.

Authors:  Erica L Jackson; Kenneth P Olive; David A Tuveson; Roderick Bronson; Denise Crowley; Michael Brown; Tyler Jacks
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

5.  Expression signature of the mouse prostate.

Authors:  Isabelle M Berquin; Younong Min; Ruping Wu; Hong Wu; Yong Q Chen
Journal:  J Biol Chem       Date:  2005-07-29       Impact factor: 5.157

6.  Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells.

Authors:  Z Zou; A Anisowicz; M J Hendrix; A Thor; M Neveu; S Sheng; K Rafidi; E Seftor; R Sager
Journal:  Science       Date:  1994-01-28       Impact factor: 47.728

7.  Susceptibility to urethan-induced pulmonary adenomas between A/J and C57BL/6J mice: use of AXB and BXA recombinant inbred lines indicating a three-locus genetic model.

Authors:  A M Malkinson; M N Nesbitt; E Skamene
Journal:  J Natl Cancer Inst       Date:  1985-11       Impact factor: 13.506

8.  Haploinsufficiency of the maspin tumor suppressor gene leads to hyperplastic lesions in prostate.

Authors:  Long-jiang Shao; Heidi Y Shi; Gustavo Ayala; David Rowley; Ming Zhang
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

9.  Maspin plays an essential role in early embryonic development.

Authors:  Fei Gao; Heidi Y Shi; Cathy Daughty; Nathalie Cella; Ming Zhang
Journal:  Development       Date:  2004-02-25       Impact factor: 6.868

10.  HDAC1 regulates pluripotency and lineage specific transcriptional networks in embryonic and trophoblast stem cells.

Authors:  Benjamin L Kidder; Stephen Palmer
Journal:  Nucleic Acids Res       Date:  2011-12-10       Impact factor: 16.971

View more
  10 in total

Review 1.  The Opportunity of Precision Medicine for Breast Cancer With Context-Sensitive Tumor Suppressor Maspin.

Authors:  Margarida M Bernardo; Sijana H Dzinic; Maria J Matta; Ivory Dean; Lina Saker; Shijie Sheng
Journal:  J Cell Biochem       Date:  2017-03-21       Impact factor: 4.429

2.  Recombinant human maspin inhibits high glucose-induced oxidative stress and angiogenesis of human retinal microvascular endothelial cells via PI3K/AKT pathway.

Authors:  Feng Qiu; Huijuan Tong; Yawen Wang; Jun Tao; Hailin Wang; Lei Chen
Journal:  Mol Cell Biochem       Date:  2018-01-23       Impact factor: 3.396

3.  Bacterial Lipopolysaccharide Augmented Malignant Transformation and Promoted the Stemness in Prostate Cancer Epithelial Cells.

Authors:  Sijie Tang; Xueqi Lian; Huiying Cheng; Jiaqian Guo; Daguang Ni; Can Huang; Xiang Gu; Hong Meng; Jiajia Jiang; Xiaohua Li
Journal:  J Inflamm Res       Date:  2021-11-09

Review 4.  Tackling tumor heterogeneity and phenotypic plasticity in cancer precision medicine: our experience and a literature review.

Authors:  Shijie Sheng; M Margarida Bernardo; Sijana H Dzinic; Kang Chen; Elisabeth I Heath; Wael A Sakr
Journal:  Cancer Metastasis Rev       Date:  2018-12       Impact factor: 9.264

5.  Role of class I histone deacetylases in the regulation of maspin expression in prostate cancer.

Authors:  Eswar Shankar; Mitali Pandey; Shiv Verma; Ata Abbas; Mario Candamo; Rajnee Kanwal; Sanjeev Shukla; Gregory T MacLennan; Sanjay Gupta
Journal:  Mol Carcinog       Date:  2020-05-11       Impact factor: 4.784

6.  Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma.

Authors:  Sijana H Dzinic; Zaid Mahdi; M Margarida Bernardo; Semir Vranic; Haya Beydoun; Nadine Nahra; Amra Alijagic; Deanna Harajli; Aaron Pang; Dan M Saliganan; Abid M Rahman; Faruk Skenderi; Berisa Hasanbegovic; Gregory Dyson; Rafic Beydoun; Shijie Sheng
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

7.  Tumor suppressor immune gene therapy to reverse immunotherapy resistance.

Authors:  Sunil Chada; Dora Wiederhold; Kerstin B Menander; Beatha Sellman; Max Talbott; John J Nemunaitis; Hyo Min Ahn; Bo-Kyeong Jung; Chae-Ok Yun; Robert E Sobol
Journal:  Cancer Gene Ther       Date:  2021-08-05       Impact factor: 5.854

8.  The roles of maspin expression in gastric cancer: a meta- and bioinformatics analysis.

Authors:  Hua-Chuan Zheng; Bao-Cheng Gong
Journal:  Oncotarget       Date:  2017-08-11

9.  Serpin functions in host-pathogen interactions.

Authors:  Jialing Bao; Guoqing Pan; Mortimer Poncz; Junhong Wei; Maoshuang Ran; Zeyang Zhou
Journal:  PeerJ       Date:  2018-04-05       Impact factor: 2.984

10.  The roles of MASPIN expression and subcellular localization in non-small cell lung cancer.

Authors:  Xiao-Fei Wang; Bo Liang; Da-Xiong Zeng; Wei Lei; Cheng Chen; Yan-Bin Chen; Jian-An Huang; Ning Gu; Ye-Han Zhu
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.